Covid-19 in Nigeria: Lockdown Measures and a Chronological Epidemiological Review During the First Wave
Abstract:
This study
provides a general epidemiological review of Corona-virus
disease in Nigeria during the first wave of the pandemic from February to
December 2020 and the efforts of the Federal Government of Nigeria (FGN) to curtail
the disease. Coronavirus disease is a highly transmissible and pathogenic viral
disease caused by severe acute
respiratory syndrome-coronavirus 2(SARS-CoV2), which emerged in Wuhan, China,
in December 2019 and later spread worldwide. The first confirmed case of the disease
in Nigeria was in February 2020, and the subject was an Italian who works in
Nigeria but returned from Milan, Italy to Lagos, after which the virus spread
to other parts of the country. In order to curtail the spread of the menace, lockdown
measures were introduced by the FGN during the first wave since there is no precise treatment for the disease, thus making
prevention
critical. Despite these measures, the
spread of Covid-19 in Nigeria continues to record a significant surge beyond
the first wave.
References:
[1] Hu, B., Guo. H., Zhou, P. and Shi.,
Z., 2021, Characteristics
of SARS-CoV-2 and Covid-19. Nature
Reviews Microbiology, 19(3),141-154. doi: 10.1038/s41579-020-00459-7.
[2] Latinne, A. et al., 2020, Origin and cross-species transmission of bat
coronaviruses in China Nature Communications, 11(1),4235. doi: 10.1038/s41467-020-17687-3.
[3] Zhu, H., Wei, L. and Niu, P., 2020, The
novel coronavirus outbreak in Wuhan, China. Global Health Research and Policy,
5(1),1–3. doi.org/10.1186/s41256-020-00135-6.
[4] World Health Organization, 2021, WHO-convened
global study of oigins of SARS-CoV-2’, Infectious Disease Immunology, Publish
Ah(February). doi: 10.1097/id9.0000000000000017.
[5] Wiersinga, W. J, et al., 2020, Pathophysiology,
transmission, diagnosis, and treatment of coronavirus disease 2019 (Covid-19): A
Review’, JAMA – Journal of the American Medical Association, 324(8),782-793.
doi: 10.1001/jama.2020.12839.
[6] World Health Organization, 2021, Statement
for healthcare professionals: How Covid-19 vaccines are regulated for safety and
effectiveness. https://www.who.int/news/item/11-06-2021-statement-for-healthcare-professionals-how-covid-19-vaccines-are-regulated-for-safety-and-effectiveness
(accessed January 10, 2022).
[7] World Health Organization, 2020, Rational
use of personal protective equipment for coronavirus disease 2019 (Covid-19). World
Health Organization, 2019(February), pp. 1–7. Available at: https://apps.who.int/iris/bitstream/handle/10665/331695/WHO-2019-nCov-IPC_PPE_use-2020.3-eng.pdf.
[8] Corman,
V.M., Muth, D., Niemeyer, D. and Drosten, C., 2018, Hosts and sources of endemic
human coronaviruses Advance in Virus Research, 100,163-188. doi: 10.1016/bs.aivir.2018.01.001.
[9] Cui, J.,
Li, F., Shi, Z.L., 2019, Origin and evolution of pathogenic coronaviruses. Nature
Reviews Microbiology, 17(3),181-192. doi: 10.1038/s41579-018-0118-9.
[10] Yang, Y., 2020, The deadly cronaviruses:
The 2003 SARS pandemic and the 2020 novel coronavirus epidemic in china, The company’s
public news and information Journal of Autoimmunity 109, p. 102487.Available
at: https://www.sciencedirect.com/science/article/pii/S0896841120300470?via%3Dihub.
[11] Abdool,
K., Salim, S. and de Oliveira, T., 2021, New SARS-CoV-2 variants-clinical, public
health, and vaccine implications New England Journal of Medicine Massachusetts, 384(19),1866-1868.
[12] Centers
for Disease Control and Prevention., 2021, New Covid-19 Variants.
[First published 11 February 2020].
[13] Lauring,
A. S. and Hodcroft, E. B., 2021, Genetic variants of SARS-CoV-2-What do they mean? . Journal of the American Medical Association, 325(6),529–531.
[14]
Swelum,
A.A. et al., 2020, ‘Covid-19 in
Human, animal, and environment: A review’, Frontiers in Veterinary Science,
7:1-13. doi: 10.3389/fvets.2020.00578.
[15]
Lauer,
S.A., et al., 2020, The incubation period of coronavirus disease 2019 (Covid-19)
from publicly reported confirmed cases: Estimation and application. Annals of
Internal fMedicine, 172(9),577–582. doi: 10.7326/M20-0504.
[16]
Paul,
S. and Lorin, E., 2021, Distribution of incubation periods of Covid-19 in the Canadian
context Science Reports, 11(1):1–9. doi: 10.1038/s41598-021-91834-8.
[17] Funk, C.D., Laferrière, C.
and Ardakani, A, 2020, Transmission and life cycle of SARS-CoV-2 causing Covid-19.
https://en.wikipedia.org/wiki/COVID-19#/media/File:Fphar-11-00937-g001.jpg.
[18] Islam,
M.A., 2021, “Prevalence
and characteristics of fever in adult and paediatric patients with coronavirus disease
2019 (COVID-19): A systematic review and meta-analysis of 17515 patients PLOS ONE. 16 (4): e0249788.
[19] Agyeman,
A.A, et al., 2020, Smell and taste dysfunction in patients with COVID-19: A systematic
review and meta-analysis Mayo Clinic Proceedings, 95(8),1621–1631.
[20] Saniasiaya,
J., Islam, M. A., and Abdullah., B., 2020. Prevalence and characteristics of taste
disorders in cases of COVID-19: A meta-analysis of 29,349 Patients. Otolaryngology–Head
and Neck Surgery 165 (1):33-42.
[21] Centers
for Disease Control and Prevention U.S, 2020a, “Interim clinical
guidance for management of patients with confirmed coronavirus disease (Covid-19)”.
[22] Centers
for Disease Control and Prevention U.S. (2020b). https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html (accessed January 10, 2022).
[23] Reuters, 2020, Italian with coronavirus in Nigeria was not isolated for
almost 24 hours. www.reuters.com/article/us-china-health-nigeria-idUSKCN20M07D.
[24] Okoroiwu, H.U, Ogar, C.O., Nja, G.M.E.,
Abunimye, D.A. and Ejemot-Nwadiaro, R.I, 2021, Covid-19 in nigeria: Account of epidemiological
events, response, management, preventions and lessons learned. Germs 11:391–402.
https://doi.org/10.18683/germs.2021.1276.
[25] World Health Organization, 2021, Covid-19
weekly epidemiological update, edition 56, 7 September 2021.
[26] International Monitoring Fund, 2021, Policy
Responses to Covid-19. Imf 2020:1–189. https://www.imf.org/en/Topics/imf-and-covid19/Policy-Responses-to-Covid-19
(accessed February 10, 2022)
[27] Milibari, A.A, 2020, iMedPub Journals
Current Situation of Coronavirus Disease : Albaraa A Milibari 10–3. https://doi.org/10.36648/1791-809X.S1.005.
[28] Organisation for Economic Cooperation
and Development (OECD), 2020, The territorial impact of Covid-19 : Managing The
Crisis Across Levels of Government. Organ
Fo Econ Coop Dev 2020:2–44.